Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines
- PMID: 35530267
- PMCID: PMC9057940
- DOI: 10.1016/j.sajb.2022.04.053
Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines
Abstract
The widespread COVID-19 pandemic, caused by novel coronavirus SARS-CoV-2, has emanated as one of the most life-threatening transmissible diseases. Currently, the repurposed drugs such as remdesivir, azithromycine, chloroquine, and hydroxychloroquine are being employed in the management of COVID-19 but their adverse effects are a matter of concern. In this regard, alternative treatment options i.e., traditional medicine, medicinal plants, and their phytochemicals, which exhibit significant therapeutic efficacy and show a low toxicity profile, are being explored. The current review aims at unraveling the promising medicinal plants, phytochemicals, and traditional medicines against SARS-CoV-2 to discover phytomedicines for the management of COVID-19 on the basis of their potent antiviral activities against coronaviruses, as demonstrated in various biochemical and computational chemical biology studies. The review consists of integrative and updated information on the potential traditional medicines against COVID-19 and will facilitate researchers to develop traditional medicines for the management of COVID-19.
Keywords: Ayurveda; COVID-19; Coronavirus; Phytochemicals; Traditional medicines.
© 2022 SAAB. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
-
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.Pain Physician. 2020 Aug;23(4S):S351-S366. Pain Physician. 2020. PMID: 32942793 Review.
-
Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.Plants (Basel). 2020 Sep 21;9(9):1244. doi: 10.3390/plants9091244. Plants (Basel). 2020. PMID: 32967179 Free PMC article. Review.
-
Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review.Phytother Res. 2023 Mar;37(3):1036-1056. doi: 10.1002/ptr.7671. Epub 2022 Nov 7. Phytother Res. 2023. PMID: 36343627 Free PMC article. Review.
-
Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective.Front Pharmacol. 2021 Apr 26;12:596855. doi: 10.3389/fphar.2021.596855. eCollection 2021. Front Pharmacol. 2021. PMID: 33981214 Free PMC article. Review.
Cited by
-
Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.Int J Mol Sci. 2022 Sep 14;23(18):10716. doi: 10.3390/ijms231810716. Int J Mol Sci. 2022. PMID: 36142620 Free PMC article. Review.
-
Herbal supplements as treatment options for COVID-19: A call for clinical development of herbal supplements for emerging and re-emerging viral threats in Sub-Saharan Africa.Sci Afr. 2023 Jul;20:e01627. doi: 10.1016/j.sciaf.2023.e01627. Epub 2023 Mar 5. Sci Afr. 2023. PMID: 36974333 Free PMC article.
References
-
- Akram M., Tahir I.M., Shah S.M.A., Mahmood Z., Altaf A., Ahamd K., Munir N., Daniyal M., Nasir S., Mehboob H. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: a systematic review. Phytother. Res. 2018;32:811–822. doi: 10.1002/ptr.6024. - DOI - PubMed
-
- Anand A.V., Balamuralikrishnan B., Kaviya M., Bharathi K., Parithathvi A., Arun M., Senthilkumar N., Velayuthaprabhu S., Saradhadevi M., Al-Dhabi N.A., Arasu M.V., Yatoo M.I., Tiwari R., Dhama K. Medicinal plants, phytochemicals, and herbs to combat viral pathogens including sars-cov-2. Molecules. 2021;26:1775. doi: 10.3390/molecules26061775. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous